{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:48:10Z","timestamp":1790621290911,"version":"4.1.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:00:00Z","timestamp":1555372800000},"content-version":"am","delay-in-days":350,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"publisher","award":["2RO1 AI071752"],"award-info":[{"award-number":["2RO1 AI071752"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"publisher","award":["3RO1 AI071752-08S1"],"award-info":[{"award-number":["3RO1 AI071752-08S1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM060655"],"award-info":[{"award-number":["GM060655"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Microbiology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.tim.2017.10.002","type":"journal-article","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T23:11:27Z","timestamp":1509664287000},"page":"436-446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["A Call to Arms: Quest for a Cryptococcal Vaccine"],"prefix":"10.1016","volume":"26","author":[{"given":"Marley C.","family":"Caballero Van Dyke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Floyd L.","family":"Wormley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tim.2017.10.002_bib0005","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.tim.2017.10.002_bib0010","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2217\/fmb.12.28","article-title":"Invasive fungal infections in solid organ transplant recipients","volume":"7","author":"Shoham","year":"2012","journal-title":"Future Microbiol."},{"key":"10.1016\/j.tim.2017.10.002_bib0015","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3201\/eid0703.017302","article-title":"Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome","volume":"7","author":"Husain","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.tim.2017.10.002_bib0020","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a019760","article-title":"Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis","volume":"4","author":"Kwon-Chung","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.tim.2017.10.002_bib0025","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4161\/viru.18685","article-title":"Molecular mechanisms of cryptococcal meningitis","volume":"3","author":"Liu","year":"2012","journal-title":"Virulence"},{"key":"10.1016\/j.tim.2017.10.002_bib0030","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/clinids\/17.5.837","article-title":"Cryptococcal meningitis and AIDS","volume":"17","author":"Powderly","year":"1993","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.tim.2017.10.002_bib0035","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/313757","article-title":"Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America","volume":"30","author":"Saag","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.tim.2017.10.002_bib0040","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.micinf.2015.08.017","article-title":"Cryptococcal transmigration across a model brain\u2013blood barrier: evidence of the Trojan horse mechanism and differences between Cryptococcus neoformans var. grubii strain H99 and Cryptococcus gattii strain R265","volume":"18","author":"Sorrell","year":"2016","journal-title":"Microbes Infect."},{"key":"10.1016\/j.tim.2017.10.002_bib0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199707033370103","article-title":"Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group","volume":"337","author":"van der Horst","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tim.2017.10.002_bib0050","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1471-2334-10-199","article-title":"A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam \u2013 high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease","volume":"10","author":"Chau","year":"2010","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.tim.2017.10.002_bib0055","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3201\/eid1405.071312","article-title":"Cryptococcus neoformans strains and infection in apparently immunocompetent patients, China","volume":"14","author":"Chen","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.tim.2017.10.002_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003272","article-title":"Retrospective study of the epidemiology and clinical manifestations of Cryptococcus gattii infections in Colombia from 1997\u20132011","volume":"8","author":"Lizarazo","year":"2014","journal-title":"PLoS Negl. Trop. Dis"},{"key":"10.1016\/j.tim.2017.10.002_bib0065","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/cid\/cir756","article-title":"Cryptococcus gattii infection in healthy hosts: a sentinel for subclinical immunodeficiency?","volume":"54","author":"Marr","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.tim.2017.10.002_bib0070","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1086\/432486","article-title":"Prevalence of clinical isolates of Cryptococcus gattii serotype C among patients with AIDS in sub-Saharan Africa","volume":"192","author":"Litvintseva","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tim.2017.10.002_bib0075","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3201\/eid1810.120068","article-title":"Autochthonous and dormant Cryptococcus gattii infections in Europe","volume":"18","author":"Hagen","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.tim.2017.10.002_bib0080","doi-asserted-by":"crossref","first-page":"e00912","DOI":"10.1128\/mBio.00912-14","article-title":"Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients","volume":"5","author":"Saijo","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.tim.2017.10.002_bib0085","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3390\/jof1020154","article-title":"Is Cryptococcus gattii a primary pathogen?","volume":"1","author":"Kwon-Chung","year":"2015","journal-title":"J. Fungi."},{"key":"10.1016\/j.tim.2017.10.002_bib0090","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/oxfordjournals.aje.a113861","article-title":"Epidemiologic differences between the two varieties of Cryptococcus neoformans","volume":"120","author":"Kwon-Chung","year":"1984","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.tim.2017.10.002_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005851","article-title":"First reported case of Cryptococcus gattii in the Southeastern USA: implications for travel-associated acquisition of an emerging pathogen","volume":"4","author":"Byrnes","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.tim.2017.10.002_bib0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028625","article-title":"Fatal disseminated Cryptococcus gattii infection in New Mexico","volume":"6","author":"Walraven","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tim.2017.10.002_bib0105","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/INF.0b013e31822d14fd","article-title":"Cryptococcus gattii genotype VGI infection in New England","volume":"30","author":"McCulloh","year":"2011","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.tim.2017.10.002_bib0110","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3201\/eid1602.090900","article-title":"Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999\u20132007","volume":"16","author":"Galanis","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.tim.2017.10.002_bib0115","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/176532","article-title":"Cryptococcus gattii: emergence in Western North America: exploitation of a novel ecological niche","volume":"2009","author":"Datta","year":"2009","journal-title":"Interdiscip. Perspect. Infect. Dis."},{"key":"10.1016\/j.tim.2017.10.002_bib0120","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3201\/eid1508.081384","article-title":"Spread of Cryptococcus gattii into Pacific Northwest region of the United States","volume":"15","author":"Datta","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.tim.2017.10.002_bib0125","unstructured":"(2010) Emergence of Cryptococcus gattii \u2013 Pacific Northwest, 2004\u20132010. MMWR Morb. Mortal Wkly Rep. 59, 865\u2013868"},{"key":"10.1016\/j.tim.2017.10.002_bib0130","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1473-3099(13)70078-1","article-title":"Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries","volume":"13","author":"Loyse","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.tim.2017.10.002_bib0135","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1086\/339680","article-title":"A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy","volume":"185","author":"Aberg","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tim.2017.10.002_bib0140","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00002030-200402200-00024","article-title":"Epidemiology of HIV-associated cryptococcosis in France (1985\u20132001): comparison of the pre- and post-HAART eras","volume":"18","author":"Dromer","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.tim.2017.10.002_bib0145","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1473-3099(07)70085-3","article-title":"Immune reconstitution syndrome associated with opportunistic mycoses","volume":"7","author":"Singh","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.tim.2017.10.002_bib0150","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/cid\/cit341","article-title":"Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii","volume":"57","author":"Chen","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.tim.2017.10.002_bib0155","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1086\/605497","article-title":"Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study","volume":"49","author":"Sungkanuparph","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.tim.2017.10.002_bib0160","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.tim.2017.10.002_bib0165","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1086\/592690","article-title":"Cryptococcosis in solid organ transplant recipients: current state of the science","volume":"47","author":"Singh","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.tim.2017.10.002_bib0170","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1086\/430606","article-title":"An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients","volume":"40","author":"Singh","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.tim.2017.10.002_bib0175","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1128\/AAC.01800-12","article-title":"Approaches to antifungal therapies and their effectiveness among patients with cryptococcosis","volume":"57","author":"Bratton","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2017.10.002_bib0180","article-title":"Association of Fcgamma receptor IIB polymorphism with cryptococcal meningitis in HIV-uninfected Chinese patients","volume":"7","author":"Hu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.tim.2017.10.002_bib0185","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1093\/infdis\/jir152","article-title":"Genotypes coding for mannose-binding lectin deficiency correlated with cryptococcal meningitis in HIV-uninfected Chinese patients","volume":"203","author":"Ou","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tim.2017.10.002_bib0190","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00573-13","article-title":"Fc gamma receptor 3A polymorphism and risk for HIV-associated cryptococcal disease","volume":"4","author":"Rohatgi","year":"2013","journal-title":"mBio"},{"key":"10.1016\/j.tim.2017.10.002_bib0195","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/ni0504-460","article-title":"Vaccine development strategies for improving immunization: the role of modern immunology","volume":"5","author":"Levine","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.tim.2017.10.002_bib0200","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1128\/IAI.67.2.936-941.1999","article-title":"The cell wall and membrane of Cryptococcus neoformans possess a mitogen for human T lymphocytes","volume":"67","author":"Mody","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2017.10.002_bib0205","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.2217\/fmb.10.93","article-title":"Mechanisms of cryptococcal virulence and persistence","volume":"5","author":"Olszewski","year":"2010","journal-title":"Future Microbiol."},{"key":"10.1016\/j.tim.2017.10.002_bib0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006854","article-title":"Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis","volume":"4","author":"Wozniak","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.tim.2017.10.002_bib0215","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1128\/IAI.68.2.456-462.2000","article-title":"Requirement for CD4+ T lymphocytes in host resistance against Cryptococcus neoformans in the central nervous system of immunized mice","volume":"68","author":"Buchanan","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2017.10.002_bib0220","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jlb.55.1.35","article-title":"The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection","volume":"55","author":"Huffnagle","year":"1994","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.tim.2017.10.002_bib0225","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1128\/iai.59.4.1423-1433.1991","article-title":"T cell-mediated immunity in the lung: a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice","volume":"59","author":"Huffnagle","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2017.10.002_bib0230","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1084\/jem.173.4.793","article-title":"Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells","volume":"173","author":"Huffnagle","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tim.2017.10.002_bib0235","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.4049\/jimmunol.144.4.1472","article-title":"Depletion of CD4+ (L3T4+) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans","volume":"144","author":"Mody","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.tim.2017.10.002_bib0240","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/imr.12063","article-title":"HIV and co-infections","volume":"254","author":"Chang","year":"2013","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.tim.2017.10.002_bib0245","first-page":"61","article-title":"Cryptococcal infections in non-HIV-infected patients","volume":"124","author":"Pappas","year":"2013","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"10.1016\/j.tim.2017.10.002_bib0250","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.idc.2006.07.001","article-title":"Cryptococcosis","volume":"20","author":"Chayakulkeeree","year":"2006","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.tim.2017.10.002_bib0255","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3389\/fmicb.2012.00291","article-title":"Vaccine and immunotherapeutic approaches for the prevention of cryptococcosis: lessons learned from animal models","volume":"3","author":"Hole","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.tim.2017.10.002_bib0260","doi-asserted-by":"crossref","first-page":"836","DOI":"10.3389\/fmicb.2015.00836","article-title":"Role of sterylglucosidase 1 (Sgl1) on the pathogenicity of Cryptococcus neoformans: potential applications for vaccine development","volume":"6","author":"Rella","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.tim.2017.10.002_bib0265","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1128\/CVI.00036-11","article-title":"Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice","volume":"18","author":"Wozniak","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.tim.2017.10.002_bib0270","doi-asserted-by":"crossref","first-page":"7920","DOI":"10.4049\/jimmunol.174.12.7920","article-title":"Generation of antifungal effector CD8+ T cells in the absence of CD4+ T cells during Cryptococcus neoformans infection","volume":"174","author":"Lindell","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.tim.2017.10.002_bib0275","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1128\/IAI.00274-06","article-title":"Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain","volume":"75","author":"Wormley","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2017.10.002_bib0280","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.chom.2011.04.006","article-title":"Trained immunity: a memory for innate host defense","volume":"9","author":"Netea","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.tim.2017.10.002_bib0285","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette\u2013Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2017.10.002_bib0290","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.chom.2012.06.006","article-title":"Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes","volume":"12","author":"Quintin","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.tim.2017.10.002_bib0295","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1128\/IAI.00935-15","article-title":"STAT1 Signaling within macrophages is required for antifungal activity against Cryptococcus neoformans","volume":"83","author":"Leopold Wager","year":"2015","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2017.10.002_bib0300","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/icb.2017.13","article-title":"Evaluation of trained immunity by beta-1, 3 (d)-glucan on murine monocytes in vitro and duration of response in vivo","volume":"95","author":"Garcia-Valtanen","year":"2017","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.tim.2017.10.002_bib0305","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0065-2164(09)01204-0","article-title":"The capsule of the fungal pathogen Cryptococcus neoformans","volume":"68","author":"Zaragoza","year":"2009","journal-title":"Adv. Appl. Microbiol."},{"key":"10.1016\/j.tim.2017.10.002_bib0310","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1128\/iai.59.10.3700-3707.1991","article-title":"Cryptococcus neoformans serotype A glucuronoxylomannan\u2013protein conjugate vaccines: synthesis, characterization, and immunogenicity","volume":"59","author":"Devi","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2017.10.002_bib0315","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1128\/IAI.67.9.4469-4476.1999","article-title":"Molecular and idiotypic analyses of the antibody response to Cryptococcus neoformans glucuronoxylomannan\u2013protein conjugate vaccine in autoimmune and nonautoimmune mice","volume":"67","author":"Nussbaum","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2017.10.002_bib0320","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0264-410X(95)00256-Z","article-title":"Preclinical efficacy of a glucuronoxylomannan\u2013tetanus toxoid conjugate vaccine of Cryptococcus neoformans in a murine model","volume":"14","author":"Devi","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.tim.2017.10.002_bib0325","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1128\/iai.65.4.1158-1164.1997","article-title":"Peptide epitopes recognized by a human anti-cryptococcal glucuronoxylomannan antibody","volume":"65","author":"Zhang","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2017.10.002_bib0330","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.4049\/jimmunol.166.2.1087","article-title":"A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection","volume":"166","author":"Fleuridor","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.tim.2017.10.002_bib0335","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1128\/CVI.00130-08","article-title":"Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannan","volume":"15","author":"Datta","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.tim.2017.10.002_bib0340","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1016\/j.vaccine.2004.03.060","article-title":"Efficacy of immune sera from human immunoglobulin transgenic mice immunized with a peptide mimotope of Cryptococcus neoformans glucuronoxylomannan","volume":"22","author":"Maitta","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.tim.2017.10.002_bib0345","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1128\/AAC.42.6.1437","article-title":"Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies","volume":"42","author":"Casadevall","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2017.10.002_bib0350","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1128\/AAC.49.3.952-958.2005","article-title":"Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis","volume":"49","author":"Larsen","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2017.10.002_bib0355","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1128\/IAI.00278-07","article-title":"An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo","volume":"75","author":"Rachini","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2017.10.002_bib0360","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1128\/CVI.00202-07","article-title":"Monoclonal antibody to fungal glucosylceramide protects mice against lethal Cryptococcus neoformans infection","volume":"14","author":"Rodrigues","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.tim.2017.10.002_bib0365","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1128\/IAI.69.5.3410-3412.2001","article-title":"Passive immunization with melanin-binding monoclonal antibodies prolongs survival of mice with lethal Cryptococcus neoformans infection","volume":"69","author":"Rosas","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2017.10.002_bib0370","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.chom.2012.04.004","article-title":"Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases","volume":"11","author":"Casadevall","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.tim.2017.10.002_bib0375","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1128\/IAI.00417-12","article-title":"Susceptibility to progressive Cryptococcus neoformans pulmonary infection is regulated by loci on mouse chromosomes 1 and 9","volume":"80","author":"Carroll","year":"2012","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2017.10.002_bib0380","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1128\/IAI.00697-15","article-title":"The Cnes2 locus on mouse chromosome 17 regulates host defense against cryptococcal infection through pleiotropic effects on host immunity","volume":"83","author":"Shourian","year":"2015","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2017.10.002_bib0385","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00547-16","article-title":"Induction of protective immunity to cryptococcal infection in mice by a heat-killed, chitosan-deficient strain of Cryptococcus neoformans","volume":"7","author":"Upadhya","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.tim.2017.10.002_bib0390","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1165\/ajrcmb.13.4.7546779","article-title":"Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice","volume":"13","author":"Hoag","year":"1995","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.tim.2017.10.002_bib0395","first-page":"177","article-title":"Chronic cryptococcal meningitis: a new experimental model in rabbits","volume":"101","author":"Perfect","year":"1980","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tim.2017.10.002_bib0400","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00578527","article-title":"Immunization of mice with an avirulent pseudohyphal form of Cryptococcus neoformans","volume":"68","author":"Fromtling","year":"1979","journal-title":"Mycopathologia"},{"key":"10.1016\/j.tim.2017.10.002_bib0405","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/00362178385380181","article-title":"Immunization of mice with stable, acapsular, yeast-like mutants of Cryptococcus neoformans","volume":"21","author":"Fromtling","year":"1983","journal-title":"Sabouraudia"},{"key":"10.1016\/j.tim.2017.10.002_bib0410","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1128\/IAI.66.6.2632-2639.1998","article-title":"Antigen-induced protective and nonprotective cell-mediated immune components against Cryptococcus neoformans","volume":"66","author":"Murphy","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2017.10.002_bib0415","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.micpath.2004.12.007","article-title":"Evaluation of host immune responses to pulmonary cryptococcosis using a temperature-sensitive C. neoformans calcineurin A mutant strain","volume":"38","author":"Wormley","year":"2005","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.tim.2017.10.002_bib0420","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01433-15","article-title":"Development of protective inflammation and cell-mediated immunity against Cryptococcus neoformans after exposure to hyphal mutants","volume":"6","author":"Zhai","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.tim.2017.10.002_bib0425","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1128\/EC.05138-11","article-title":"Cell wall chitosan is necessary for virulence in the opportunistic pathogen Cryptococcus neoformans","volume":"10","author":"Baker","year":"2011","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.tim.2017.10.002_bib0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.11.1.1","article-title":"Use of licensed vaccines for active immunization of the immunocompromised host","volume":"11","author":"Pirofski","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.tim.2017.10.002_bib0435","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1128\/iai.56.2.424-431.1988","article-title":"Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens","volume":"56","author":"Murphy","year":"1988","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2017.10.002_bib0440","doi-asserted-by":"crossref","first-page":"10422","DOI":"10.1073\/pnas.181331398","article-title":"Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses to Cryptococcus neoformans","volume":"98","author":"Levitz","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2017.10.002_bib0445","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1128\/IAI.70.10.5485-5493.2002","article-title":"Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-cell responses","volume":"70","author":"Huang","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2017.10.002_bib0450","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1086\/520536","article-title":"Contribution of glycosylation to T cell responses stimulated by recombinant Cryptococcus neoformans mannoprotein","volume":"196","author":"Specht","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tim.2017.10.002_bib0455","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1567-1364.2006.00071.x","article-title":"The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins","volume":"6","author":"Levitz","year":"2006","journal-title":"FEMS Yeast Res."},{"key":"10.1016\/j.tim.2017.10.002_bib0460","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1128\/IAI.73.2.820-827.2005","article-title":"Mannoproteins from Cryptococcus neoformans promote dendritic cell maturation and activation","volume":"73","author":"Pietrella","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2017.10.002_bib0465","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002046","article-title":"Cooperative stimulation of dendritic cells by Cryptococcus neoformans mannoproteins and CpG oligodeoxynucleotides","volume":"3","author":"Dan","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.tim.2017.10.002_bib0470","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.4049\/jimmunol.167.7.3988","article-title":"Potent inhibition of neutrophil migration by cryptococcal mannoprotein-4-induced desensitization","volume":"167","author":"Coenjaerts","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.tim.2017.10.002_bib0475","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1128\/IAI.72.3.1746-1754.2004","article-title":"Protective efficacy of antigenic fractions in mouse models of cryptococcosis","volume":"72","author":"Mansour","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2017.10.002_bib0480","doi-asserted-by":"crossref","first-page":"7348","DOI":"10.1128\/IAI.73.11.7348-7355.2005","article-title":"Characterization of two novel cryptococcal mannoproteins recognized by immune sera","volume":"73","author":"Biondo","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2017.10.002_bib0485","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.1365-2249.1999.00821.x","article-title":"Heat shock protein 70 (hsp70) as a major target of the antibody response in patients with pulmonary cryptococcosis","volume":"115","author":"Kakeya","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.tim.2017.10.002_bib0490","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1128\/iai.65.5.1653-1658.1997","article-title":"A 77-kilodalton protein of Cryptococcus neoformans, a member of the heat shock protein 70 family, is a major antigen detected in the sera of mice with pulmonary cryptococcosis","volume":"65","author":"Kakeya","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2017.10.002_bib0495","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1002\/pmic.200800713","article-title":"A proteomic-based approach for the identification of immunodominant Cryptococcus neoformans proteins","volume":"9","author":"Young","year":"2009","journal-title":"Proteomics"},{"key":"10.1016\/j.tim.2017.10.002_bib0500","doi-asserted-by":"crossref","first-page":"6196","DOI":"10.1128\/IAI.68.11.6196-6201.2000","article-title":"The Cryptococcus neoformans gene DHA1 encodes an antigen that elicits a delayed-type hypersensitivity reaction in immune mice","volume":"68","author":"Mandel","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2017.10.002_bib0505","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1128\/IAI.70.5.2383-2391.2002","article-title":"Identification and cloning of a cryptococcal deacetylase that produces protective immune responses","volume":"70","author":"Biondo","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2017.10.002_bib0510","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1128\/IAI.71.9.5412-5417.2003","article-title":"Induction of T helper type 1 responses by a polysaccharide deacetylase from Cryptococcus neoformans","volume":"71","author":"Biondo","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2017.10.002_bib0515","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104316","article-title":"Vaccine-mediated immune responses to experimental pulmonary Cryptococcus gattii infection in mice","volume":"9","author":"Chaturvedi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.tim.2017.10.002_bib0520","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1002\/pmic.201300213","article-title":"Identification and characterization of Cryptococcus neoformans protein fractions that induce protective immune responses","volume":"13","author":"Chaturvedi","year":"2013","journal-title":"Proteomics"},{"key":"10.1016\/j.tim.2017.10.002_bib0525","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002257","article-title":"Hsp90 governs dispersion and drug resistance of fungal biofilms","volume":"7","author":"Robbins","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tim.2017.10.002_bib0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000471","article-title":"Hsp90 orchestrates stress response signaling governing fungal drug resistance","volume":"5","author":"Cowen","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tim.2017.10.002_bib0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000532","article-title":"Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin","volume":"5","author":"Singh","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tim.2017.10.002_bib0540","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1126\/science.1118370","article-title":"Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi","volume":"309","author":"Cowen","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.tim.2017.10.002_bib0545","doi-asserted-by":"crossref","first-page":"e01905","DOI":"10.1128\/mBio.01905-15","article-title":"Protection against experimental cryptococcosis following vaccination with glucan particles containing Cryptococcus alkaline extracts","volume":"6","author":"Specht","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.tim.2017.10.002_bib0550","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153853","article-title":"Glucosylceramide administration as a vaccination strategy in mouse models of cryptococcosis","volume":"11","author":"Mor","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.tim.2017.10.002_bib0555","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1074\/jbc.M114.616300","article-title":"Sterylglucoside catabolism in Cryptococcus neoformans with endoglycoceramidase-related protein 2 (EGCrP2), the first steryl-beta-glucosidase identified in fungi","volume":"290","author":"Watanabe","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tim.2017.10.002_bib0560","first-page":"3702","article-title":"A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors","volume":"8","author":"Giaccone","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tim.2017.10.002_bib0565","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1586\/14760584.7.10.1519","article-title":"Glycolipid ligands of invariant natural killer T cells as vaccine adjuvants","volume":"7","author":"Kim","year":"2008","journal-title":"Exp. Rev. Vaccines"},{"key":"10.1016\/j.tim.2017.10.002_bib0570","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/08830180601070179","article-title":"The in vivo response of invariant natural killer T cells to glycolipid antigens","volume":"26","author":"Parekh","year":"2007","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.tim.2017.10.002_bib0575","doi-asserted-by":"crossref","first-page":"11441","DOI":"10.1158\/0008-5472.CAN-06-0944","article-title":"Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide","volume":"66","author":"Yanagisawa","year":"2006","journal-title":"Cancer Res."}],"container-title":["Trends in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X17302299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X17302299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:38:56Z","timestamp":1760812736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966842X17302299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":115,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0966842X17302299"],"URL":"https:\/\/doi.org\/10.1016\/j.tim.2017.10.002","relation":{},"ISSN":["0966-842X"],"issn-type":[{"value":"0966-842X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Call to Arms: Quest for a Cryptococcal Vaccine","name":"articletitle","label":"Article Title"},{"value":"Trends in Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tim.2017.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}